Welcome to CDC stacks | Imaging Mass Spectrometry of Diversified Cardiolipin Molecular Species in the Brain - 31814 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Imaging Mass Spectrometry of Diversified Cardiolipin Molecular Species in the Brain
Filetype[PDF-4.35 MB]


Details:
  • Pubmed ID:
    24949523
  • Pubmed Central ID:
    PMC4082390
  • Description:
    MALDI imaging mass spectrometry (MALDI-IMS) has been used successfully in mapping different lipids in tissue sections, yet existing protocols fail to detect the diverse species of mitochondria-unique cardiolipins (CLs) in the brain which are essential for cellular and mitochondrial physiology. We have developed methods enabling the imaging of individual CLs in brain tissue. This was achieved by eliminating ion suppressive effects by (i) cross-linking carboxyl/amino containing molecules on tissue with 1-ethyl-3-[3-(dimethylamino)propyl]-carbodiimide hydrochloride and (ii) removing highly abundant phosphatidylcholine head groups via phospholipase C treatment. These treatments allowed the detection of CL species at 100 μm resolution and did not affect the amount or molecular species distribution of brain tissue CLs. When combined with augmented matrix application, these modifications allowed the visualization and mapping of multiple CL species in various regions of the brain including the thalamus, hippocampus, and cortex. Areas such as the dentate and stratum radiatum exhibited higher CL signals than other areas within the hippocampal formation. The habenular nuclear (Hb)/dorsal third ventricle (D3 V) and lateral ventricle (LV) areas were identified as CL "hot spots". Our method also allowed structural MS/MS fragmentation and mapping of CLs with identified fatty acid residues and demonstrated a nonrandom distribution of individual oxidizable (polyunsaturated fatty acid containing) and nonoxidizable (nonpolyunsaturated containing) CLs in different anatomical areas of the brain. To our knowledge, this method is the first label-free approach for molecular mapping of diversified CLs in brain tissue.

  • Document Type:
  • Collection(s):
  • Funding:
    ES020693/ES/NIEHS NIH HHS/United States
    ES021068/ES/NIEHS NIH HHS/United States
    NS061817/NS/NINDS NIH HHS/United States
    NS076511/NS/NINDS NIH HHS/United States
    OH008282/OH/NIOSH CDC HHS/United States
    P01 HL114453/HL/NHLBI NIH HHS/United States
    P30CA047904/CA/NCI NIH HHS/United States
    R01 NS061817/NS/NINDS NIH HHS/United States
    R01 NS076511/NS/NINDS NIH HHS/United States
    U19 AI068021/AI/NIAID NIH HHS/United States
    U19AI068021/AI/NIAID NIH HHS/United States
    U54 GM103529 08/GM/NIGMS NIH HHS/United States
No Related Documents.
You May Also Like: